Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R,5aR,8aR,9R),5aβ,8aα,9β(R*)]]-

Englisch Name:: Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-

Synonyma:: Etoposide EP impurity R (S configuration);Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...;Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 10

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R,5aR,8aR,9R),5aβ,8aα,9β(R*)]]- Eigenschaften

Global( 10)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Moxin Chemicals	+86-17320513646 +8617320513646	anna@molcoo.com	China	10000	58
TOSUN PHARM	020-66392521-118 18922260391	3004261881@qq.com	China	7978	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736	2853117764@yongstandards.com	China	9999	58
Henan Vcommend Consultrading Co., Ltd.	13393721940	sales@vcommend.com	China	9963	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	18126517264	2850476883@qq.com	China	7902	58
Cato Research Chemicals Inc.	81960175 18933936954	2853283383@qq.com	China	11421	58
Chengdu Peter-like Biotechnology Co., Ltd.	028-81700200 13308200041	2851167782@qq.com	China	10935	58
Hubei Rhema Reference Materials Technology Co., Ltd.	15787879035 15787875101	ydw9035@rmastandards.com	China	9918	58
TLC Pharmaceutical Standards Ltd.	18012923235	chinasales04@tlcstandards.com.cn	China	8291	58
Nanxiong Puqiang Biology Science and Technology Co., Ltd	15702096460 13602449734	wp838873168@163.com	China	1742	58

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
Etoposide EP impurity R (S configuration)
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...
149839-65-6